| Active Not Recruiting | A MULTICENTER, SEEKING SIGNAL, RANDOMISED, OPEN-LABEL PHASE II OF RELATLIMAB AND NIVOLUMAB VS NIVOLUMAB ALONE LOCALLY ADVANCED CERVICAL CANCERS | Phase 2 | 2024-12-11 |
| Completed | Efficacy Assessment of Lenvatinib Associated with Pembrolizumab in Metastatic Endometrial Cancer: a French Mul Metastatic Endometrial Cancer | — | 2024-08-19 |
| Recruiting | Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patient Ovarian Cancer | Phase 3 | 2024-07-30 |
| Recruiting | Validation of KELIM as a Predictive/Prognostic Factor for Maintenance Treatment With iPARP in First-Line Ovari Ovarian Cancer | — | 2023-12-11 |
| Completed | Patients Characteristics, Treatment Pattern & Outcomes of Patients With Advanced, Recurrent or Metastatic Endo Oncology, Endometrial Cancer, Advanced Cancer | — | 2022-05-09 |
| Active Not Recruiting | Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line Endometrial Cancer | Phase 3 | 2022-04-15 |
| Recruiting | Niraparib With beVAcizumab After Complete cytoreductioN in Patients With ovArian Cancer Ovarian Cancer | Phase 2 | 2022-02-01 |
| Active Not Recruiting | OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC Platinum-sensitive Ovarian Cancer, Relapsed Ovarian Cancer | Phase 2 | 2021-08-05 |
| Recruiting | Addition of Pembrolizumab to the Standard of Care Chemotherapy in Patient With SCCOHT Small Cell Ovarian Carcinoma | Phase 2 | 2021-08-04 |
| Recruiting | Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib Ovarian Carcinosarcoma, Endometrial Carcinosarcoma | Phase 2 / Phase 3 | 2020-07-15 |
| Completed | COL Immunotherapy Before Radiochimio + Ipilimumab Cervix Cancer | N/A | 2020-07-02 |
| Completed | Genomic BRCA and Extensive ovArian Cancer Testing Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer | — | 2019-12-06 |
| Completed | NIraparib and Quality of LifE is a Longitudinal Study Evaluating in Real Life the Tolerability of Niraparib. Ovarian Cancer | Phase 4 | 2019-04-03 |
| Unknown | Tri Association in Patient With Advanced Epithelial Ovarian Cancer in Relapse Epithelial Ovarian Cancer, Relapse | Phase 2 | 2019-03-01 |
| Completed | UTOLA: UTerin OLAparib Endometrial Carcinoma | Phase 2 | 2019-02-01 |
| Completed | Retarded Surgery Following Neoadjuvant Chemotherapy in Advanced Ovarian Cancer Ovarian Cancer Stage IV, Ovarian Cancer Stage IIIC, Ovarian Cancer Stage IIIb | N/A | 2018-10-19 |
| Completed | Real-life Data of Olaparib in Relapsed Ovarian Cancers Patients Relapsed Ovarian Cancers Patients | — | 2018-10-11 |
| Completed | PEMBRO With Chemo in Neo Adj Treatment of Ovarian Cancer . Ovarian Cancer Stage IV | Phase 2 | 2018-02-26 |
| Completed | Immunotherapy With Neo-adjuvant Chemotherapy for OVarian Cancer Ovarian Cancer | Phase 1 / Phase 2 | 2017-10-18 |
| Completed | ATALANTE: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bev Ovarian Cancer | Phase 3 | 2016-09-22 |
| Terminated | Addition of Aromatase at the Navelbine in Pretreated Metastatic Breast Cancer. Breast Cancer | Phase 2 | 2015-10-23 |
| Completed | REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progress Ovarian Carcinoma | Phase 2 | 2015-08-28 |
| Completed | Paclitaxel/Pazopanib for Platinum Resistant/Refractory Ovarian Cancer Ovarian Cancer | Phase 2 | 2015-06-15 |
| Completed | Ovarian Cancer Treatment Platinum-sensitive Relapse - Cohort Study (PROSPECTYON) Ovarian Cancer | — | 2014-07-10 |
| Completed | First Line Metastatic Breast Cancer Treatment (ESMERALDA) Metastatic Breast Cancer | Phase 2 | 2013-11-01 |
| Completed | First Line Ovarian Cancer Treatment - Cohort Study Epithelial Ovarian Cancer | — | 2013-04-01 |
| Completed | Efficacy and Safety of Bevacizumab (Avastin®) Combined to Weekly Paclitaxel Followed by Bevacizumab (Avastin®) Ovarian Sex-cord Stromal Tumor | Phase 2 | 2013-02-01 |
| Completed | Myocet ® - Carboplatine in Ovarian Cancer in Relapse, Sensitive to the Platinum Ovarian Cancer | Phase 1 / Phase 2 | 2012-10-01 |
| Completed | Vargatef in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Ovarian Cance Ovarian Cancer | Phase 2 | 2012-06-01 |
| Completed | GINECO-EN102b - BKM120 as Monotherapy in the Treatment of Initial or Recurrent Metastatic Endometrial Cancer Endometrial Cancer | Phase 2 | 2011-12-01 |
| Terminated | 1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer First Line Metastatic Breast Cancer | Phase 3 | 2010-06-01 |
| Terminated | Bevacizumab + Paclitaxel + Capecitabine in Triple Negative Metastatic Breast Cancer Triple Negative Metastatic Breast Cancer | Phase 2 | 2010-04-01 |
| Completed | A 2 Stage Trial of Lenalidomide (REV) in Asymptomatic Ovarian Cancer Patients With Increasing CA 125 in Late R Ovarian Cancer Recurrent | Phase 1 / Phase 2 | 2009-05-01 |
| Completed | Carboplatin and Topotecan in Treating Patients With Relapsed or Metastatic Cervical Cancer Cervical Cancer | Phase 1 / Phase 2 | 2008-09-01 |
| Completed | Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast Cancer Breast Cancer | Phase 2 | 2008-03-01 |
| Completed | Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer Breast Neoplasms, mTor Protein | Phase 2 | 2008-03-01 |
| Completed | Everolimus in Treating Patients With Relapsed or Metastatic Endometrial Cancer Endometrial Cancer | Phase 2 | 2008-03-01 |
| Terminated | Phase II Study , Association of Cisplatine Topotecan and Cetuximab in Patients Whith Late or in Progress Epith Cervix Cancer | Phase 2 | 2007-04-01 |
| Completed | Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questio Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms | Phase 2 | 2006-02-01 |
| Completed | Capecitabine Associated With Weekly Paclitaxel in Metastatic Breast Cancer. Breast Cancer, Neoplasm Metastasis | Phase 2 | 2005-12-01 |
| Completed | Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Ovarian Cancer, Fallopian Tube Cancer | Phase 3 | 2005-04-01 |
| Completed | Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Canc Ovarian Cancer, Fallopian Tube Cancer, Malignant Tumor of Peritoneum | Phase 2 | 2004-04-01 |
| Completed | Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer Metastatic Breast Cancer | Phase 2 | 2004-02-01 |
| Completed | Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer Metastatic Breast Cancer | Phase 3 | 2003-07-01 |
| Completed | CAmpto-CISplatine Plus Radiotherapy in Advanced Cervix Cancer : Search of Tolerated Maximum Dose of Campto Cervix Cancer | Phase 1 | 2002-11-01 |
| Completed | French Observatory of Rare Malignant Tumors of the Ovary Ovarian Tumors | — | 2002-01-01 |
| Completed | The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer Pancreatic Neoplasms, Biliary Tract Neoplasms | Phase 2 | 2001-08-01 |
| Completed | Evaluation of the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Olde Ovarian Cancer | Phase 2 | 2001-01-01 |
| Terminated | Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer Ovarian Cancer | Phase 2 | — |